Bragar Eagel & Squire is Investigating Certain Officers and Directors of C3.ai, Ginkgo Bioworks, and Polished on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors C3.ai, Inc. (NYSE: AI), Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), and Polished.com, Inc. (NYSEAmerican: POL) on behalf of long-term stockholders. More information about each potential case can be found at the link provided.
C3.ai, Inc. (NYSE: AI)
Bragar Eagel & Squire is investigating certain officers and directors of C3.ai, Inc. following a class action complaint that was filed against C3.ai.
The complaint alleges that the Registration Statement and Prospectus (together, the "Offering Documents") issued in connection with the Company's initial public offering were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Additionally, defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, the Offering Documents and defendants made false and/or misleading statements and/or failed to disclose that: (i) C3.ai's partnership with Baker Hughes was deteriorating; (ii) C3.ai's was employing a flawed accounting methodology to conceal the deterioration of its Baker Hughes partnership; (iii) C3.ai faced challenges in product adoption and significant salesforce turnover; (iv) the Company overstated, inter alia, the extent of its investment in technology, description of its customers, its total addressable market, the pace of its market growth, and the scale of alliances with its major business partners; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times. |
